Greenville, SC4 Active Studies

Pulmonary Embolism Clinical Trials in Greenville, SC

Find 4 actively recruiting pulmonary embolism clinical trials in Greenville, SC. Connect with local research sites and explore new treatment options.

4
Active Trials
3
Sponsors
316
Enrolling

Recruiting Pulmonary Embolism Studies in Greenville

RecruitingGreenville, SCNCT06722235

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Primary immune thrombocytopenia (ITP) is a condition where the immune system mistakenly destroys platelets, which are cells that help stop bleeding. This leads to a low number of platelets, making it ...

171 participants
Takeda
View Study Details
RecruitingGreenville, SCNCT06783309

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending doses of CNP-103. The approximately 208-da...

72 participants
COUR Pharmaceutical Development Company, Inc.
View Study Details
RecruitingGreenville, SCNCT07059000

A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)

The purpose of this study is to evaluate the efficacy and safety of KIg 10 (Intravenous Immunoglobulin 10%) in adult patients with chronic primary ITP...

40 participants
Kedrion S.p.A.
View Study Details
RecruitingGreenville, SCNCT05714969

A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)

This is a study of TAK-755 in adults with immune-mediated thrombotic thrombocytopenic purpura (iTTP). The main aim of this study is to determine the percentage of participants with a clinical (Part 1)...

33 participants
Takeda
View Study Details

About Pulmonary Embolism Clinical Trials in Greenville

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 4 pulmonary embolism clinical trials recruiting participants in Greenville, SC. These studies are seeking a combined 316 participants. Research is being sponsored by Takeda, COUR Pharmaceutical Development Company, Inc., Kedrion S.p.A.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Greenville — FAQ

Are there pulmonary embolism clinical trials in Greenville?

Yes, there are 4 pulmonary embolism clinical trials currently recruiting in Greenville, SC. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Greenville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Greenville research site will contact you about next steps.

Are clinical trials in Greenville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Greenville studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 4 active trials in Greenville are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated March 2, 2026 from ClinicalTrials.gov